DSPE-PEG1000-K237
DSPE-PEG1000-K237 is a PEG compound which composed of DSPE and a KDR targeting peptide (K237) . K237 can functionally disrupt the interaction between VEGF and the KDR receptor and cause potent biological effects that include the inhibition of angiogenesis and tumor growth. DSPE-PEG1000-K237 can be used for drug delivery[1].
Product Specifications
UNSPSC
12352200
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Mal-Cys-HTMYYHHYQHHL]C(CCOCCOC(NCCOP(OC[C@](COC(CCCCCCCCCCCCCCCCC)=O)([H])OC(CCCCCCCCCCCCCCCCC)=O)(O)=O)=O)=O.[n]
Molecular Weight
1000 (Average)
References & Citations
[1]Hetian L, et al. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. J Biol Chem. 2002 Nov 8;277 (45) :43137-42.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400977-100 1x 100 µL
TGF-beta (1D11.16.8), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942497-500 1x 500 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/2497R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042131-500 1x 500 µL
Mesothelin (Mesothelial Marker) (MSLN/2131), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041219-100 1x 100 µL
Cytokeratin 8 (B22.1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741959-500 1x 500 µL
Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) (KRT19/1959R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details